Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New artemisinin derivatives from Hong Kong active against sensitive and resistant malarial strains

Feb. 15, 2000

Biovail acquires Canadian marketing rights for Ampligen

Feb. 15, 2000

Components of naturally occurring antimicrobial complex isolated at Schering-Plough

Feb. 14, 2000

Microbiotix and BioChem Pharma to develop novel antibiotic agents

Feb. 14, 2000

Bayer and marketing partners introduce new fluoroquinolone in Spain

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

Phase III trials to begin for BioCryst's influenza therapy

Feb. 10, 2000

Dainippon and Questcor modify antibacterial research agreement

Feb. 9, 2000

Antiinfluenza sialic acid derivatives emerge from R&D at RIKEN

Feb. 8, 2000

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.